Clinical Trial: A Randomized, Double-Blind, Parallel Placebo-Controlled Trial on the Efficacy of HellenCare in Alzheimer's Disease

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895525) titled 'A Randomized, Double-Blind, Parallel Placebo-Controlled Trial on the Efficacy of HellenCare in Alzheimer's Disease' on March 19.

Brief Summary: The goal of this clinical trial is to evaluate whether HellenCare, a multicomponent nutraceutical, improves cognitive and functional outcomes in patients with early-stage Alzheimer's disease (AD). We will compare changes in outcomes between the HellenCare group and the placebo group to determine if the intervention is effective and safe.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Alzheimer's Disease Dementia

Intervention: DIETARY_SUPPLEMENT: HellenCare

2 g, twic...